Zhen Pang

Zhen Pang has extensive work experience in the biopharmaceutical industry, spanning over 25 years. Currently, Zhen Pang holds the position of VP, Head of Business Development at Reistone Biopharma, a role that began in August 2022. Prior to this, Zhen Pang worked at Hope Medicine Inc as the VP of BD&L from June 2021 to March 2023.

From 2018 to 2021, Zhen Pang served as the Sr. Director of Global Business Development at I-Mab Biopharma. At Jing Medicine (Shanghai) LTD., Zhen Pang held the position of VP, Head of Biology from November 2017 to April 2018.

Zhen Pang's work experience also includes a role as the Scientific Director at Crown Bioscience, Inc. from August 2015 to June 2016.

Zhen Pang's early career includes positions at Sanofi Genzyme as a Principal Research Investigator, where they provided scientific and technical support for various projects related to immune-mediated diseases and immuno-inflammation.

Prior to Sanofi Genzyme, Zhen Pang worked at Roche as a Research Scientist in the CNS TA/Genetics & Genomics department from 2001 to 2005. They also had a role as a Postdoctoral Fellow in Metabolic Disorders at Merck from 2000 to 2001.

Zhen Pang began their career as a Postdoctoral Research Associate in Developmental Neurobiology at St. Jude Children's Research Hospital from 1997 to 2000. During this time, they conducted research on the precerebellin gene family and made significant advancements in the field.

Zhen Pang has a Master's Degree in Molecular Genetics of Microbes from the Institute of Microbiology, Chinese Academy of Sciences. Additionally, Zhen Pang holds a Doctor of Philosophy (Ph.D.) in Anatomy and Neurobiology, with a specialization in the Sanders-Brown Center on Aging, from the University of Kentucky. Zhen Pang also completed a Bachelor's Degree in Virology and Molecular Biology from Wuhan University.